<SEC-DOCUMENT>0001354457-23-000547.txt : 20230727
<SEC-HEADER>0001354457-23-000547.hdr.sgml : 20230727
<ACCEPTANCE-DATETIME>20230727160613
ACCESSION NUMBER:		0001354457-23-000547
CONFORMED SUBMISSION TYPE:	25-NSE
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20230727
DATE AS OF CHANGE:		20230727
EFFECTIVENESS DATE:		20230727

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADIAL PHARMACEUTICALS, INC.
		CENTRAL INDEX KEY:			0001513525
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				800667150
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25-NSE
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38323
		FILM NUMBER:		231118425

	BUSINESS ADDRESS:	
		STREET 1:		1180 SEMINOLE TRAIL
		STREET 2:		SUITE 495
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22901
		BUSINESS PHONE:		434-422-9800

	MAIL ADDRESS:	
		STREET 1:		1180 SEMINOLE TRAIL
		STREET 2:		SUITE 495
		CITY:			CHARLOTTESVILLE
		STATE:			VA
		ZIP:			22901

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADial Pharmaceuticals, L.L.C.
		DATE OF NAME CHANGE:	20170515

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Adial Pharmaceuticals, L.L.C.
		DATE OF NAME CHANGE:	20110218

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nasdaq Stock Market LLC
		CENTRAL INDEX KEY:			0001354457
		IRS NUMBER:				521165937
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		25-NSE

	BUSINESS ADDRESS:	
		STREET 1:		One Liberty Plaza
		CITY:			New York
		STATE:			NY
		ZIP:			10006
		BUSINESS PHONE:		301-978-4144

	MAIL ADDRESS:	
		STREET 1:		Office of General Counsel
		STREET 2:		805 King Farm Blvd.
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	The Nasdaq Stock Market LLC
		DATE OF NAME CHANGE:	20060224
</SEC-HEADER>
<DOCUMENT>
<TYPE>25-NSE
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001354457</cik>
        <entityName>Nasdaq Stock Market LLC</entityName>
    </exchange>

    <issuer>
        <cik>0001513525</cik>
        <entityName>ADIAL PHARMACEUTICALS, INC.</entityName>
        <fileNumber>001-38323</fileNumber>
        <address>
            <street1>1180 Seminole Trail , Suite 495</street1>
            <street2></street2>
            <city>CHARLOTTESVILLE</city>
            <stateOrCountryCode>VA</stateOrCountryCode>
            <stateOrCountry>VIRGINIA</stateOrCountry>
            <zipCode>22901</zipCode>
        </address>
        <telephoneNumber>(434) 422-9800</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Warrant</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(a)(2)</ruleProvision>

    <signatureData>
        <signatureName>Tara Petta</signatureName>
        <signatureTitle>Director</signatureTitle>
        <signatureDate>2023-07-27</signatureDate>
    </signatureData>
</notificationOfRemoval>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.25
<SEQUENCE>2
<FILENAME>adilw-form25.txt
<TEXT>
Adilw-form25
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
